Novellus

1 stories about Novellus
default image

Biological cancer treatment company Novellus raises $57 million

22.09.20|Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer